July 25, 2017 10:12 PM ET

Biotechnology

Company Overview of KaloBios Pharmaceuticals, Inc.

Key Executives for KaloBios Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Cameron Durrant M.D., MBA58 RelationshipsChairman of the Board and Chief Executive Officer 57
David L. Tousley M.B.A., CPA11 RelationshipsInterim Chief Financial Officer61
Charles J. Democko No RelationshipsSenior Vice President of Regulatory Affairs and Quality62

KaloBios Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Cameron Durrant M.D., MBA 58 RelationshipsKaloBios Pharmaceuticals, Inc.57
James W. Larrick M.D., Ph.D. 42 RelationshipsKaloBios Pharmaceuticals, Inc.--
Ronald Barliant J.D. 5 RelationshipsKaloBios Pharmaceuticals, Inc.72
Timothy Morris CPA 5 RelationshipsKaloBios Pharmaceuticals, Inc.55
Dale Chappell M.D., MBA 5 RelationshipsBlack Horse Capital Advisors LLC47
View All Board Members

KaloBios Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee CPATimothy Morris5 Relationships3 Executives
Compensation Committee M.D., MBACameron Durrant58 Relationships2 Executives
Nominating Committee J.D.Ronald Barliant5 Relationships2 Executives
Corporate Governance Committee J.D.Ronald Barliant5 Relationships2 Executives
Advisory Board M.D., Ph.D.James W. Larrick42 Relationships1 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$500.0K
500.0K
390.2K
Bonus
Not meaningful
Total Short Term Compensation
Not meaningful
Total Value of Options$500.0K
500.0K
18.3M
Compensation as of Fiscal Year 2016
KaloBios Pharmaceuticals, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Intellia Therapeutics Inc. Announces Executive Changes
July 24, 2017 10:30 PM ET
PTC Therapeutics, Inc. Announces the Promotion of Joseph McIntosh to Senior Vice President and Head of Clinical Development
July 24, 2017 8:30 PM ET
Biogen Appoints Alisha A. Alaimo as Senior Vice President of US Therapeutic Operations
July 24, 2017 8:15 PM ET
Microbix Biosystems Inc. Announces Executive Changes
July 24, 2017 12:59 PM ET
Vaxil Bio Ltd. Appoints Terry Plasse as Chief Medical Officer
July 24, 2017 12:46 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact KaloBios Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.